Insomnia drug should be classified under Schedule IV, DEA says

Drug Enforcement Administration proposes placing indiplon in Schedule IV

The Drug Enforcement Administration has proposed placing DEA proposal appeared in the Jan. 31 issue of the Federal Register.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.


Related Videos
© 2023 MJH Life Sciences

All rights reserved.